You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Avelumab

Showing 1 - 25 of 262
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Bicalutamide 150 mg
  • Placebo
  • Québec, Canada
    CHU de Québec - Université Laval
Sep 6, 2023

Avelumab in Real-World Treatment for Advanced or Metastatic

Not yet recruiting
  • Bladder Cancer
  • Avelumab
  • (no location specified)
Nov 21, 2022

Breast Cancer Trial (Avelumab, Aspirin, Lansoprazole)

Not yet recruiting
  • Breast Cancer
  • Avelumab
  • +2 more
  • (no location specified)
Feb 2, 2023

Avelumab First-Line Maintenance in Canadian People With Advanced

Not yet recruiting
  • Urinary Bladder Neoplasms
  • +3 more
  • Avelumab first-line maintenance
  • Mississauga, Ontario, Canada
    Bayshore Specialty Rx
Jan 24, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Avelumab and Pepinemab
  • Rochester, New York
    University of Rochester Medical Center
Jan 19, 2023

Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023

Metastatic Cancer, Urothelial Carcinoma Trial (avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin)

Not yet recruiting
  • Metastatic Cancer
  • Urothelial Carcinoma
  • avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
  • (no location specified)
Dec 19, 2022

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jan 18, 2023

Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

Active, not recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Avelumab
  • Ballarat, Victoria, Australia
  • +2 more
Jan 30, 2023

Glioblastoma Multiforme of Brain Trial in Gatineau (avelumab)

Completed
  • Glioblastoma Multiforme of Brain
  • avelumab
  • Gatineau, Quebec, Canada
    Clinique Neuro-Outaouais
Jul 19, 2022

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Gastroesophageal Junction Adenocarcinoma, Stomach Tumors Trial in Barcelona (Avelumab addition to perioperative chemo in GC and

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Stomach Neoplasms
  • Avelumab addition to perioperative chemotherapy in GC and GEJC
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Oct 11, 2022

Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 18, 2022

Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

Active, not recruiting
  • Leptomeningeal Metastases
  • Leptomeningeal Disease
  • Avelumab
  • Whole Brain Radiotherapy
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022

Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Meningioma
  • Meningioma, Adult
  • Avelumab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 27, 2022

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

Terminated
  • POLE Exonuclease Mutant Colon Cancer
  • +2 more
  • Avelumab
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Oct 5, 2022

Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Jun 27, 2022

Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Avelumab
  • +3 more
  • Jette, Brussels, Belgium
  • +1 more
Sep 9, 2022

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Avelumab
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • London, United Kingdom
    University College Hospital
May 17, 2022

Osteosarcoma Trial in United States (Avelumab, Questionnaires)

Active, not recruiting
Has Results
  • Osteosarcoma
  • Avelumab
  • Questionnaires
  • Los Angeles, California
  • +3 more
Aug 22, 2022